Clinical Trials Sponsored by Alcyone Therapeutics
Total 7131 results
-
Alcyone Therapeutics, IncBiogenRecruitingScoliosis | Spinal Muscular Atrophy | Spine DeformityUnited States
-
Megan WaldropAlcyone TherapeuticsEnrolling by invitation
-
Alcyone Lifesciences, Inc.CompletedHydrocephalyUnited States
-
Ranok Therapeutics (Hangzhou) Co., Ltd.RecruitingAdvanced Solid Tumor | DLBCLUnited States
-
Akebia TherapeuticsCyclerion TherapeuticsCompletedType 2 Diabetes Mellitus With Diabetic NephropathyUnited States
-
Akebia TherapeuticsCyclerion TherapeuticsCompletedHeart Failure With Preserved Ejection FractionUnited States, Canada
-
Halcyon DermatologyCompleted
-
Eikon TherapeuticsImpact Therapeutics, Inc.RecruitingAdvanced Solid TumorAustralia, United States
-
CRISPR Therapeutics AGActive, not recruitingRenal Cell CarcinomaUnited States, Australia, Canada, Netherlands
-
APRINOIA Therapeutics, LLCActive, not recruitingAlzheimer Disease | Tauopathies | Healthy VolunteersUnited States
-
CRISPR Therapeutics AGRecruitingClear Cell Renal Cell Carcinoma | Pancreatic Adenocarcinoma | Cervical Carcinoma | Malignant Pleural Mesothelioma | Esophageal CarcinomaUnited States
-
CRISPR Therapeutics AGActive, not recruitingT Cell LymphomaUnited States, Australia, Canada
-
CRISPR Therapeutics AGActive, not recruitingB-cell Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Adult B Cell ALLUnited States, Spain, Canada, France, Germany, Australia
-
Bacainn Therapeutics, Inc.CompletedHealthy VolunteersUnited States
-
Celsus Therapeutics PLCTerminatedAtopic DermatitisIsrael
-
CRISPR Therapeutics AGRecruitingFollicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Large B-cell Lymphoma | Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)United States
-
CRISPR Therapeutics AGEnrolling by invitationHematologic Malignancy | Solid MalignancyUnited States, Australia
-
CRISPR Therapeutics AGActive, not recruitingMultiple MyelomaUnited States, Spain, Australia, Canada
-
APRINOIA Therapeutics, LLCActive, not recruitingHealthy Volunteers | Alzheimer's Disease | Mild Cognitive Impairment Due to Alzheimer's DiseaseUnited States
-
Skyline Therapeutics (US) Inc.RecruitingNeovascular Age-related Macular DegenerationChina, United States
-
iCell Gene TherapeuticsiCar Bio TherapeuticsRecruitingRelapsed/Refractory, High Risk Hematologic Malignancies | T-ALL/LymphomaChina
-
Arthrosi TherapeuticsRecruitingHyperuricemia | Gout | Arthritis, Gouty | Gout ChronicUnited States, Australia, New Zealand
-
Quanta TherapeuticsRecruiting
-
Highlight TherapeuticsRecruitingBasal Cell CarcinomaIsrael
-
Neurona TherapeuticsNot yet recruitingEpilepsy, Temporal Lobe
-
Aliada TherapeuticsRecruitingAlzheimer DiseaseUnited States
-
Tisento TherapeuticsNot yet recruitingMitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)United States, Australia, Italy, Germany, Canada, United Kingdom
-
Kyverna TherapeuticsNot yet recruitingSystemic Sclerosis | Systemic Sclerosis - Diffuse Cutaneous | Systemic Sclerosis - 2013 ACR/EULAR Classification Criteria
-
Eilean TherapeuticsRecruiting
-
United TherapeuticsNot yet recruitingPulmonary Hypertension | Interstitial Lung Disease | Pulmonary Hypertension Due to Lung Diseases and Hypoxia
-
Kyverna TherapeuticsNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive
-
Eilean TherapeuticsNot yet recruiting
-
Skyline TherapeuticsRecruitingNeovascular (Wet) Age-related Macular DegenerationChina, United States
-
Starna TherapeuticsNot yet recruitingRespiratory Syncytial Virus Infections
-
Kyverna TherapeuticsRecruitingLupus Nephritis | Lupus Nephritis - WHO Class IV | Lupus Nephritis - WHO Class IIIGermany
-
Nektar TherapeuticsRecruitingAlopecia AreataUnited States, Canada
-
Cybrexa TherapeuticsNot yet recruitingPlatinum-resistant Ovarian Cancer | Refractory Ovarian Carcinoma
-
Cartesian TherapeuticsRecruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
TransCode TherapeuticsNot yet recruiting
-
Valerio TherapeuticsRecruitingBreast Cancer | Prostate Cancer | Advanced or Metastatic Solid Tumors | Recurrent Ovarian CancerUnited States
-
Eikon TherapeuticsRecruiting
-
Kyverna TherapeuticsNot yet recruitingGeneralized Myasthenia Gravis | Myasthenia Gravis
-
Causeway TherapeuticsRecruiting
-
Compass TherapeuticsRecruitingHodgkin Lymphoma | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Head and Neck Squamous Cell Carcinoma | Malignant MelanomaUnited States
-
PYC TherapeuticsRecruitingOptic Atrophies, Hereditary | Autosomal Dominant Optic Atrophy | Optic Atrophy, Autosomal Dominant | Kjer Optic AtrophyAustralia
-
MC2 TherapeuticsRecruitingEfficacy and Safety of MC2-25 Cream & Vehicle in Women With Vulvar Lichen Sclerosus (VLS) (Orchid 1)Vulvar Lichen SclerosusDenmark
-
Remix TherapeuticsRecruitingAdenoid Cystic Carcinoma | Metastatic Adenoid Cystic Carcinoma | Recurrent Adenoid Cystic CarcinomaUnited States
-
Contineum TherapeuticsRecruitingRelapsing Remitting Multiple SclerosisUnited States
-
Virion TherapeuticsRecruitingChronic Hepatitis BHong Kong, New Zealand
-
Chimeric TherapeuticsRecruitingGastric Cancer | Colorectal Cancer | Neuroendocrine TumorsUnited States